Dysferlin deficiency and the development of cardiomyopathy in a mouse model of limb-girdle muscular dystrophy 2B

American Journal of Pathology

Volumn 175, Issue 6, 2009, Pages 2299-2308

  Chase, Thomas H ^a   Cox, Gregory A ^a   Burzenski, Lisa ^a   Foreman, Oded ^a   Shultz, Leonard D ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSFERLIN;

ABSENCE; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CADAVER; CARDIOMYOPATHY; CELL DAMAGE; CELL MEMBRANE; CELL STRUCTURE; CONSCIOUSNESS; DISEASE COURSE; DYSFERLIN DEFICIENCY; ECHOCARDIOGRAPHY; FUNCTIONAL DISEASE; HEART FUNCTION; HEART MUSCLE CELL; IN VIVO STUDY; LIMB GIRDLE MUSCULAR DYSTROPHY; MEMBRANE DAMAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SARCOPLASM; SKELETAL MUSCLE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 73549116514     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080930     Document Type: Article

References (24)

1. Clarke MS, Caldwell RW, Chiao H, Miyake K, McNeil PL: Contraction-induced cell wounding and release of fibroblast growth factor in heart. Circ Res 1995, 76:927-934
2. Miyake K, McNeil PL: Mechanical injury and repair of cells. Crit Care Med 2003, 31:S496-S501
3. Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, McNeil PL, Campbell KP: Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 2003, 423:168-172
4. Liu J, Aoki M: Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi Myopathy and limb girdle muscular dystrophy 2B. Nat Genet 1998, 20:31-36
5. Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, Lako M, Richard I, Marchand S, Bourg N, Argov Z, Sadeh M, Mahjneh I, Marconi G, Passos-Bueno MR, Moreira Ede S, Zatz M, Beckmann JS, Bushby K: A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 1998, 20:37-42
6. Anderson LV, Davison K, Moss JA, Young C, Cullen MJ, Walsh J, Johnson MA, Bashir R, Britton S, Keers S, Argov Z, Mahjneh I, Fougerousse F, Beckmann JS, Bushby KM: Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet 1999, 8:855-861
7. Matsuda C, Aoki M, Hayashi YK, Ho MF, Arahata K, Brown RH, Jr: Dysferlin is a surface membrane-associated protein that is absent in Miyoshi myopathy. Neurology 1999, 53:1119-1122
8. Han R, Bansal D, Miyake K, Muniz VP, Weiss RM, McNeil PL, Campbell KP: Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. J Clin Invest 2007, 117:1805-1813
9. Lennon NJ, Kho A, Bacskai BJ, Perlmutter SL, Hyman BT, Brown RH, Jr: Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem 2003, 278:50466-50473
10. Kuru S, Yasuma F, Wakayama T, Kimura S, Konagaya M, Aoki M, Tanabe M, Takahashi T: A patient with limb girdle muscular dystrophy type 2B (LGMD2B) manifesting cardiomyopathy. Rinsho Shinkeigaku 2004, 44:375-378
11. Wenzel K, Geier C, Qadri F, Hubner N, Schulz H, Erdmann B, Gross V, Bauer D, Dechend R, Dietz R, Osterziel KJ, Spuler S, Ozcelik C: Dysfunction of dysferlin-deficient hearts. J Mol Med 2007, 85:1203-1214
12. Ho M, Post CM, Donahue LR, Lidov HG, Bronson RT, Goolsby H, Watkins SC, Cox GA, Brown RH, Jr: Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum Mol Genet 2004, 13:1999-2010
13. Vasiljevic JD, Popovic ZB, Otasevic P, Popovic ZV, Vidakovic R, Miric M, Neskovic AN: Myocardial fibrosis assessment by semiquantitative, point-counting and computer-based methods in patients with heart disease: a comparative study. Histopathology 2001, 38:338-343
14. Gaspard GJ, Pasumarthi KB: Quantification of cardiac fibrosis by colour-subtractive computer-assisted image analysis. Clin Exp Pharmacol Physiol 2008, 35:679-686
15. Maddatu TP, Garvey SM, Schroeder DG, Hampton TG, Cox GA: Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy. Hum Mol Genet 2004, 13:1105-1115
16. Sutton P: Measurements in Cardiology. 1999
17. Bittner RE, Anderson LV, Burkhardt E, Bashir R, Vafiadaki E, Ivanova S, Raffelsberger T, Maerk I, Hoger H, Jung M, Karbasiyan M, Storch M, Lassmann H, Moss JA, Davison K, Harrison R, Bushby KM, Reis A: Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet 1999, 23:141-142
18. Challice C, Viragh S: Ultrastructure of the Mammalian Heart. New York, Academic Press, 1973, pp 19-23
19. Brette F, Orchard C: Resurgence of cardiac t-tubule research. Physiology 2007, 22:167-173
20. Cheng CF, Kuo HC, Chien KR: Genetic modifiers of cardiac arrhythmias. Trends Mol Med 2003, 9:59-66
21. Rucker-Martin C, Milliez P, Tan S, Decrouy X, Recouvreur M, Vranckx R, Delcayre C, Renaud JF, Dunia I, Segretain D, Hatem SN: Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts. Cardiovasc Res 2006, 72:69-79
22. Basso C, Czarnowska E, Della Barbera M, Bauce B, Beffagna G, Wlodarska EK, Pilichou K, Ramondo A, Lorenzon A, Wozniek O, Corrado D, Daliento L, Danieli GA, Valente M, Nava A, Thiene G, Rampazzo A: Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies. Eur Heart J 2006, 27:1847-1854
23. Sheikh F, Chen Y, Liang X, Hirschy A, Stenbit AE, Gu Y, Dalton ND, Yajima T, Lu Y, Knowlton KU, Peterson KL, Perriard JC, Chen J: Alpha-E-catenin inactivation disrupts the cardiomyocyte adherens junction, resulting in cardiomyopathy and susceptibility to wall rupture. Circulation 2006, 114:1046-1055
24. Kumar V, Abbas A, Fausto N: Pathologic Basis of Disease. Philadelphia, Elsevier Saunders, 2005, pp 14-34